<p><b>A</b>. After transduction, ALDH1A3 expression was determined by western blot. The expression of ALDH1A3 was significantly reduced by shRNA targeting ALDH1A3 as measured by densitometry (normalized to GAPDH). <b>B</b>. The number of invaded cells was significantly decreased in ALDH1A3 knockdown cells as compared with control. <b>C</b>. The quantitative results for the transwell experiment. <b>D</b>. The expression of tumor invasion associated proteins was reduced by ALDH1A3 knockdown. Each experiment was performed in triplicates. * p<0.05.</p
<p><b>A</b>. Kaplan-Meier estimates of survival for 177 HGG patients (OS ≥ 60 days) with genome-wide...
Glioblastoma (GBM) is the most aggressive primary brain tumor and is resistant to all therapeutic re...
<p>(A) Relative DHS-mRNA expression in G55T2 and U87-MG cells after lentiviral transduction with a s...
<p>SW480 cells were transfected with ALDH1B1 shRNA or scramble shRNA to develop stable cell colonies...
<p>Lentiviral vectors expressing ALDH1A1 specific shRNAs or nontargeting shRNAs were transfected int...
Glioblastoma (GBM) is the most aggressive malignant glioma. Therapeutic targeting of GBM is made mor...
<p>Flow cytometry was conducted in SW480 cells transfected with either ALDH1B1 shRNA or scramble shR...
<p>(<b>A</b>) For the Wnt/β-catenin reporter assay, scramble or ALDH1B1 shRNA transfected SW480 cell...
<p>U87MG cells transduced with gal-3 shRNA demonstrated decreased gal-3 protein by western blot (<b>...
Accumulating data shows that altered metabolic activity contributes to glioma development. Recently,...
Elevated aldehyde dehydrogenase (ALDH) activity correlates with poor outcome for many solid tumors a...
In Panel A western blot analysis confirms an shRNA-mediated reduction in protein expression of the G...
: Aldehyde dehydrogenase 1A3 (ALDH1A3), one of the three members of the aldehyde dehydrogenase 1A su...
Aldehyde dehydrogenase 1 isoforms A1 and A3 have been implicated as functional biomarkers associated...
Elevated aldehyde dehydrogenase (ALDH) activity correlates with poor outcome for many solid tumors a...
<p><b>A</b>. Kaplan-Meier estimates of survival for 177 HGG patients (OS ≥ 60 days) with genome-wide...
Glioblastoma (GBM) is the most aggressive primary brain tumor and is resistant to all therapeutic re...
<p>(A) Relative DHS-mRNA expression in G55T2 and U87-MG cells after lentiviral transduction with a s...
<p>SW480 cells were transfected with ALDH1B1 shRNA or scramble shRNA to develop stable cell colonies...
<p>Lentiviral vectors expressing ALDH1A1 specific shRNAs or nontargeting shRNAs were transfected int...
Glioblastoma (GBM) is the most aggressive malignant glioma. Therapeutic targeting of GBM is made mor...
<p>Flow cytometry was conducted in SW480 cells transfected with either ALDH1B1 shRNA or scramble shR...
<p>(<b>A</b>) For the Wnt/β-catenin reporter assay, scramble or ALDH1B1 shRNA transfected SW480 cell...
<p>U87MG cells transduced with gal-3 shRNA demonstrated decreased gal-3 protein by western blot (<b>...
Accumulating data shows that altered metabolic activity contributes to glioma development. Recently,...
Elevated aldehyde dehydrogenase (ALDH) activity correlates with poor outcome for many solid tumors a...
In Panel A western blot analysis confirms an shRNA-mediated reduction in protein expression of the G...
: Aldehyde dehydrogenase 1A3 (ALDH1A3), one of the three members of the aldehyde dehydrogenase 1A su...
Aldehyde dehydrogenase 1 isoforms A1 and A3 have been implicated as functional biomarkers associated...
Elevated aldehyde dehydrogenase (ALDH) activity correlates with poor outcome for many solid tumors a...
<p><b>A</b>. Kaplan-Meier estimates of survival for 177 HGG patients (OS ≥ 60 days) with genome-wide...
Glioblastoma (GBM) is the most aggressive primary brain tumor and is resistant to all therapeutic re...
<p>(A) Relative DHS-mRNA expression in G55T2 and U87-MG cells after lentiviral transduction with a s...